DIFFUSION PHARMACEUTICALS IN - COM PAR

CUSIP: 253748305

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / COM PAR
Total 13F shares
9,962,324
Share change
+32,792
Total reported value
$7,273,000
Price per share
$0.73
Number of holders
23
Value change
-$62,666
Number of buys
12
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 253748305?
CUSIP 253748305 identifies 253748305 - DIFFUSION PHARMACEUTICALS IN - COM PAR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of DIFFUSION PHARMACEUTICALS IN - COM PAR as of Q2 2021

As of 30 Jun 2021, DIFFUSION PHARMACEUTICALS IN - COM PAR was held by 23 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,962,324 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Virtu Financial LLC, NORTHERN TRUST CORP, CITADEL ADVISORS LLC, Raymond James Financial Services Advisors, Inc., and Yu Fan. This page lists 23 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.